ACMI - Accumed Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sigmund who wrote (1283)	1/28/1998 6:12:00 PM
From: Cisco	Read Replies (2) of 1894

Sigmund, According to the NPTH press release: ®The PMA supplement requests approval to use the AutoPap System as an initial screener, identifying 25% of slides which receive AutoPap review only and may be archived as normal. The remaining 75% of the slides have the highest probability of containing abnormal cells. These will then be manually screened and will include a 15% subset subjected to federally mandated Quality Control rescreening. ¯ Am I reading this correctly?? 75% of the slides must be rescreened manually. Of these 75%, 15% must be screened a third time. This would mean that if you were screening 100 slides using the AutoPap System, there would still be 87 manual screenings still required! No wonder people are asking if it is cost effective. Cisco

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next